Statin therapy and autoimmune disease: from protein prenylation to immunomodulation

J Greenwood, L Steinman, SS Zamvil - Nature reviews immunology, 2006 - nature.com
Statins have been prescribed extensively for their cholesterol-lowering properties and
efficacy in cardiovascular disease. However, compelling evidence now exists that statins …

Adaptive immunity and atherosclerosis

J Andersson, P Libby, GK Hansson - Clinical immunology, 2010 - Elsevier
Atherosclerosis involves the formation of inflammatory arterial lesions and is one of the most
common causes of death globally. It has been evident for more than 20 years that adaptive …

The mevalonate pathway is a druggable target for vaccine adjuvant discovery

Y Xia, Y Xie, Z Yu, H Xiao, G Jiang, X Zhou, Y Yang… - Cell, 2018 - cell.com
Motivated by the clinical observation that interruption of the mevalonate pathway stimulates
immune responses, we hypothesized that this pathway may function as a druggable target …

Molecular mechanisms of neuroimmune crosstalk in the pathogenesis of stroke

YH Choi, C Laaker, M Hsu, P Cismaru… - International Journal of …, 2021 - mdpi.com
Stroke disrupts the homeostatic balance within the brain and is associated with a significant
accumulation of necrotic cellular debris, fluid, and peripheral immune cells in the central …

Molecular targets of statins and their potential side effects: Not all the glitter is gold

KK Patel, VS Sehgal, K Kashfi - European journal of pharmacology, 2022 - Elsevier
Statins are a class of drugs widely used worldwide to manage hypercholesterolemia and the
prevention of secondary heart attacks. Currently, available statins vary in terms of their …

Dendritic cells in atherosclerosis: current status of the problem and clinical relevance

YV Bobryshev - European heart journal, 2005 - academic.oup.com
Dendritic cells (DCs) are the most potent antigen-presenting cells. DCs were identified in
arteries in 1995 and, since then, further knowledge has been gained indicating the …

[HTML][HTML] The regulation of immune cells by Lactobacilli: a potential therapeutic target for anti-atherosclerosis therapy

YH Ding, LY Qian, J Pang, JY Lin, Q Xu, LH Wang… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Atherosclerosis is an inflammatory disease regulated by several immune cells including
lymphocytes, macrophages and dendritic cells. Gut probiotic bacteria like Lactobacilli have …

Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque …

JK Damås, C Smith, E Øie, B Fevang… - … , and vascular biology, 2007 - Am Heart Assoc
Objective—Based on their role in T-cell homing into nonlymphoid tissue, we examined the
role of the homeostatic chemokines CCL19 and CCL21 and their common receptor CCR7 in …

Dendritic cells in atherosclerotic disease

A Niessner, CM Weyand - Clinical immunology, 2010 - Elsevier
Atherosclerosis has been considered a syndrome of dysregulated lipid storage until recent
evidence has emphasized the critical contribution of the immune system. Dendritic cells …

Statin treatment in multiple sclerosis: a systematic review and meta-analysis

G Pihl-Jensen, A Tsakiri, JL Frederiksen - CNS drugs, 2015 - Springer
Background Multiple sclerosis (MS) is a chronic inflammatory disease that leads to
progressive disability. Statins [hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors] …